Unichem Pharmaceuticals USA Inc. recalls
4 notices naming Unichem Pharmaceuticals USA Inc. as the recalling firm, since September 24, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Unichem Pharmaceuticals USA Inc.: busPIRone Hydrochloride Tablets
Hazard (FDA): Subpotent drug
FDAMedicines
Unichem Pharmaceuticals USA Inc.: Doxazosin Tablets
Hazard (FDA): Tablets/Capsules Imprinted with Wrong ID
FDAMedicines
Unichem Pharmaceuticals USA Inc.: Bisoprolol Fumarate and Hydrochlorothiazide tablets
Hazard (FDA): cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
FDAMedicines
Unichem Pharmaceuticals USA Inc.: Cyclobenzaprine Hydrochloride Tablets
Hazard (FDA): Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).
FDAMedicines